QUIDELORTHO CORP Incremental Common Shares Attributable to Dilutive Effect of Conversion of Debt Securities
QUIDELORTHO CORP (QDEL) reported Incremental Common Shares Attributable to Dilutive Effect of Conversion of Debt Securities of 0 shares for the 12-month period ending 2023-01-01, per its 10-K filed 2023-02-23.
Discontinued › Income Statement › Earnings Per Share
us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities · last filed 2023-02-23
- QUIDELORTHO CORP incremental common shares attributable to dilutive effect of conversion of debt securities for fiscal 2023 was 0.00 shares.
- QUIDELORTHO CORP incremental common shares attributable to dilutive effect of conversion of debt securities for fiscal 2022 was 0.00 shares, a 100.00% decline from fiscal 2021.
- QUIDELORTHO CORP incremental common shares attributable to dilutive effect of conversion of debt securities for fiscal 2021 was 300.00K shares.
| Period end | Incremental Common Shares Attributable to Dilutive Effect of Conversion of Debt Securities 12 month |
|---|---|
| 2023-01-01 | 0.00 shares 10-K · filed 2023-02-23 |
| 2022-01-02 | 0.00 shares 10-K · filed 2023-02-23 |
| 2021-01-03 | 300.00K shares 10-K · filed 2023-02-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |